Missing: xABT's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: xABT's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing xABT
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
xABT is included in 4 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Latest xABT News
Aug 27, 2021
PRNewsWire India BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to support Vientiane's efforts at epidemic prevention and control in 2021. At the same time, the deputy director of the Vientiane's foreign affairs office, sent a letter of thanks to XABT on behalf of the Vientiane Municipal Government and Epidemic Prevention and Control Committee.During the last coronavirus outbreak in Laos in April this year, XABT donated 5,040 Multiple Real Time PCR Kits for Detection of 2019-nCoV and provided full technical service support to Vientiane to help the city control the spread of the disease through in-depth international cooperation.Virus knows no borders, but the worst of times reveals the best in people. Since the outbreak of COVID-19, XABT has undertaken corporate social responsibility with practical actions and donated nucleic acid detection and extraction kits to Italy, Iran, Malaysia, Thailand, Peru and Bangladesh to support their fights against the epidemic. The company will continue to make positive contributions to continue the effort at controlling the epidemic worldwide. Nucleic acid detection is an important testing and screening method for 2019-nCoV used by the World Health Organization (WHO) and national health authorities. XABT, among all the companies that have obtained the registration certificate from the National Medical Products Administration of China for the coronavirus nucleic acid detection reagent, is one of the few high-tech companies producing the rapid detection technology covering three genes, ORF1ab, N and E. The company's 2019-nCoV nucleic acid detection kit (fluorescence PCR method) can achieve up to 99.9% accuracy due to the specific binding at the molecular level and was included in the WHO Emergency Use Listing in May 2020. The company has received the ISO13485 system certification, and its products, all of which conform to the EU's CE certification standards, are being adopted by more and more countries as a tool to control and prevent the further spread of the virus as well as being recognized as the most effective solution by more and more organizations.For more information:Company website: http://www.x-abt.com/en/ LinkedIn, Facebook, YouTubePhoto - https://mma.prnewswire.com/media/1598762/image_1.jpgPhoto - https://mma.prnewswire.com/media/1598763/image_2.jpg Advertisements
xABT Web Traffic
xABT Frequently Asked Questions (FAQ)
When was xABT founded?
xABT was founded in 2010.
Where is xABT's headquarters?
xABT's headquarters is located at 1F, Block B, Zhengdan International, Beijing.
What is xABT's latest funding round?
xABT's latest funding round is Series B.
How much did xABT raise?
xABT raised a total of $7.08M.
Who are the investors of xABT?
Investors of xABT include Zero2IPO Venture Capital, bioVENTURE, WanSheng Capital and xABT.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.